Form 8-K - Current report:
SEC Accession No. 0001558370-24-000593
Filing Date
2024-01-26
Accepted
2024-01-26 16:45:19
Documents
13
Period of Report
2024-01-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mxct-20240123x8k.htm   iXBRL 8-K 41241
2 EX-10.1 mxct-20240123xex10d1.htm EX-10.1 104872
  Complete submission text file 0001558370-24-000593.txt   289921

Data Files

Seq Description Document Type Size
3 EX-101.SCH mxct-20240123.xsd EX-101.SCH 3129
4 EX-101.LAB mxct-20240123_lab.xml EX-101.LAB 15917
5 EX-101.PRE mxct-20240123_pre.xml EX-101.PRE 10319
7 EXTRACTED XBRL INSTANCE DOCUMENT mxct-20240123x8k_htm.xml XML 4840
Mailing Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850
Business Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850 301-517-5556
MAXCYTE, INC. (Filer) CIK: 0001287098 (see all company filings)

EIN.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40674 | Film No.: 24568574
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)